Cyclophosphamide, thalidomide and dexamethasone (CTD) as initial therapy for newly diagnosed multiple myeloma patients

Authors :: Karina Mayra Aliaga Llerena
Luis Casanova
Daniel J Enriquez
Fernando Valencia
Rossana Esther Ruiz Mendoza
Jule Franve Vasquez Chavez
Victor Palacios
Source :: Journal of Clinical Oncology. 34:8051-8051
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 8051Background: Major progress has occurred in multiple myeloma (MM) treatment in recent years. . However, due to limited healthcare resources, newer agents are not readily available. In this setti...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Cyclophosphamide/Thalidomide
Newly diagnosed
medicine.disease
Internal medicine
medicine
CTD
business
Initial therapy
Multiple myeloma
Dexamethasone
medicine.drug

Full Text Access

Tools